{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:18:42Z","timestamp":1778642322867,"version":"3.51.4"},"reference-count":52,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cancer Society of Finland, Sigrid Jus\u00e9lius Foundation and Academy of Finland","award":["313267"],"award-info":[{"award-number":["313267"]}]},{"name":"Cancer Society of Finland, Sigrid Jus\u00e9lius Foundation and Academy of Finland","award":["310507"],"award-info":[{"award-number":["310507"]}]},{"name":"Cancer Society of Finland, Sigrid Jus\u00e9lius Foundation and Academy of Finland","award":["295504"],"award-info":[{"award-number":["295504"]}]},{"name":"Cancer Society of Finland, Sigrid Jus\u00e9lius Foundation and Academy of Finland","award":["292611"],"award-info":[{"award-number":["292611"]}]},{"name":"Cancer Society of Finland, Sigrid Jus\u00e9lius Foundation and Academy of Finland","award":["277293"],"award-info":[{"award-number":["277293"]}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Program","award":["634143"],"award-info":[{"award-number":["634143"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/bib\/bby119","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T20:12:19Z","timestamp":1542744739000},"source":"Crossref","is-referenced-by-count":21,"title":["Interactive visual analysis of drug\u2013target interaction networks using Drug Target Profiler, with applications to precision medicine and drug repurposing"],"prefix":"10.1093","author":[{"given":"Ziaurrehman","family":"Tanoli","sequence":"first","affiliation":[{"name":"Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid","family":"Alam","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr","family":"Ianevski","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland"},{"name":"Helsinki Institute for Information Technology, Aalto University, Espoo, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krister","family":"Wennerberg","sequence":"additional","affiliation":[{"name":"University of Copenhagen, Biotech Research & Innovation Centre (BRIC)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"V\u00e4h\u00e4-Koskela","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tero","family":"Aittokallio","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland"},{"name":"Helsinki Institute for Information Technology, Aalto University, Espoo, Finland"},{"name":"Department of Mathematics and Statistics, University of Turku, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"key":"key\n\t\t\t\t2019012510585940600_ref1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t2019012510585940600_ref2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nchembio.1867","article-title":"The promise and peril of chemical probes","volume":"11","author":"Arrowsmith","year":"2015","journal-title":"Nat Chem Biol"},{"key":"key\n\t\t\t\t2019012510585940600_ref3","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","article-title":"The ChEMBL bioactivity database: an update","volume":"42","author":"Bento","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019012510585940600_ref4","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019012510585940600_ref5","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gkw1118","article-title":"PubChem BioAssay: 2017 update","volume":"45","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019012510585940600_ref6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chembiol.2017.11.009","article-title":"Drug Target Commons: a community effort to build a consensus knowledge base for drug\u2013target interactions","volume":"25","author":"Tang","year":"2018","journal-title":"Cell Chem Biol"},{"key":"key\n\t\t\t\t2019012510585940600_ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/database\/bay083","article-title":"Drug Target Commons 2.0: a community platform for systematic analysis of drug\u2013target interaction profiles","volume":"2018","author":"Tanoli","year":"2018","journal-title":"Database (Oxford)"},{"key":"key\n\t\t\t\t2019012510585940600_ref8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019012510585940600_ref9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019012510585940600_ref10","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/2159-8290.CD-15-0235","article-title":"Harnessing connectivity in a large-scale small-molecule sensitivity dataset","volume":"5","author":"Seashore-Ludlow","year":"2015","journal-title":"Cancer Discov"},{"key":"key\n\t\t\t\t2019012510585940600_ref11","doi-asserted-by":"crossref","first-page":"D994","DOI":"10.1093\/nar\/gkx911","article-title":"PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies","volume":"46","author":"Smirnov","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019012510585940600_ref12","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bby069","article-title":"Review and comparative assessment of similarity-based methods for prediction of drug\u2013protein interactions in the druggable human proteome","author":"Wang","year":"2018","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t2019012510585940600_ref13","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bby061","article-title":"Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases","author":"Rifaioglu","year":"2018","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t2019012510585940600_ref14","article-title":"Computational prediction of drug\u2013target interactions using chemogenomic approaches: an empirical survey","author":"Ezzat","year":"2018","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t2019012510585940600_ref15","article-title":"Web-based drug repurposing tools: a survey","author":"Sam","year":"2017","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t2019012510585940600_ref16","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbx045","article-title":"In silico polypharmacology of natural products","author":"Fang","year":"2017","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t2019012510585940600_ref17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/bib\/bbx017","article-title":"A review of network-based approaches to drug repositioning","volume":"19","author":"Lotfi Shahreza","year":"2017","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t2019012510585940600_ref18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/bib\/bbv066","article-title":"Drug\u2013target interaction prediction: databases, web servers and computational models","volume":"17","author":"Chen","year":"2015","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t2019012510585940600_ref19","first-page":"333","article-title":"SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug\u2013target interactions and drug repositioning","volume":"18","author":"Wu","year":"2016","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t2019012510585940600_ref20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2174\/1389203718666161114111656","article-title":"RFDT: a rotation forest-based predictor for predicting drug\u2013target interactions using drug structure and protein sequence information","volume":"19","author":"Wang","year":"2018","journal-title":"Curr Protein Pept Sci"},{"key":"key\n\t\t\t\t2019012510585940600_ref21","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/ijc.29897","article-title":"DrugTargetInspector: an assistance tool for patient treatment stratification","volume":"138","author":"Schneider","year":"2016","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t2019012510585940600_ref22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bib\/bbw136","article-title":"Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning","volume":"19","author":"Shameer","year":"2017","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t2019012510585940600_ref23","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-018-0297-4","article-title":"Probing the chemical\u2013biological relationship space with the Drug Target Explorer","volume":"10","author":"Allaway","year":"2018","journal-title":"Journal of Cheminformatics"},{"key":"key\n\t\t\t\t2019012510585940600_ref24","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: augmenting protein\u2013chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019012510585940600_ref25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nbt.3080","article-title":"A comprehensive transcriptional portrait of human cancer cell lines","volume":"33","author":"Klijn","year":"2015","journal-title":"Nat Biotechnol"},{"key":"key\n\t\t\t\t2019012510585940600_ref26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature12831","article-title":"Inconsistency in large pharmacogenomic studies","volume":"504","author":"Haibe-Kains","year":"2013","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019012510585940600_ref27","doi-asserted-by":"crossref","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019012510585940600_ref28","doi-asserted-by":"crossref","DOI":"10.1186\/1758-2946-5-3","article-title":"UniChem: a unified chemical structure cross-referencing and identifier tracking system","volume":"5","author":"Chambers","year":"2013","journal-title":"J Cheminform"},{"key":"key\n\t\t\t\t2019012510585940600_ref29","doi-asserted-by":"crossref","first-page":"D204","DOI":"10.1093\/nar\/gku989","article-title":"UniProt: a hub for protein information","volume":"43","author":"UniProt Consortium","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019012510585940600_ref30","doi-asserted-by":"crossref","first-page":"D285","DOI":"10.1093\/nar\/gkt1180","article-title":"PDBe: protein data bank in Europe","volume":"42","author":"Gutmanas","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019012510585940600_ref31","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019012510585940600_ref32","doi-asserted-by":"crossref","first-page":"D183","DOI":"10.1093\/nar\/gkw1138","article-title":"PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements","volume":"45","author":"Mi","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019012510585940600_ref33","doi-asserted-by":"crossref","first-page":"D279","DOI":"10.1093\/nar\/gkv1344","article-title":"The Pfam protein families database: towards a more sustainable future","volume":"44","author":"Finn","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2019012510585940600_ref34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/leu.2008.334","article-title":"Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells","volume":"23","author":"Rix","year":"2009","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t2019012510585940600_ref35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/leu.2008.295","article-title":"Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1\/CSF1R signaling abnormalities in the cell line GDM1","volume":"23","author":"Chase","year":"2009","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t2019012510585940600_ref36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2008.10.014","article-title":"Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib","volume":"599","author":"Day","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t2019012510585940600_ref37","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/blood-2007-05-092056","article-title":"Effective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src\/Abl kinase inhibitor SKI-606","volume":"111","author":"Konig","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019012510585940600_ref38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nchembio.1085","article-title":"Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML","volume":"8","author":"Winter","year":"2012","journal-title":"Nat Chem Biol"},{"key":"key\n\t\t\t\t2019012510585940600_ref39","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1182\/blood-2017-05-782292","article-title":"Midostaurin approved for FLT3-mutated AML","volume":"129","author":"Levis","year":"2017","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019012510585940600_ref40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1158\/2159-8290.CD-12-0357","article-title":"Noncovalent wild-type-sparing inhibitors of EGFR T790M","volume":"3","author":"Lee","year":"2013","journal-title":"Cancer Discov"},{"key":"key\n\t\t\t\t2019012510585940600_ref41","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat Biotechnol"},{"key":"key\n\t\t\t\t2019012510585940600_ref42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1021\/jm301581y","article-title":"Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region\u2013Abelson (Bcr\u2013Abl) kinase and overcomes clinically acquired mutation-induced resistance against imatinib","volume":"56","author":"Ren","year":"2013","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t2019012510585940600_ref43","doi-asserted-by":"crossref","first-page":"e1003226","DOI":"10.1371\/journal.pcbi.1003226","article-title":"Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways","volume":"9","author":"Tang","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"key\n\t\t\t\t2019012510585940600_ref44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nchembio.1986","article-title":"Correlating chemical sensitivity and basal gene expression reveals mechanism of action","volume":"12","author":"Rees","year":"2016","journal-title":"Nat Chem Biol"},{"key":"key\n\t\t\t\t2019012510585940600_ref45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/bib\/bbu010","article-title":"Toward more realistic drug\u2013target interaction predictions","volume":"16","author":"Pahikkala","year":"2014","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t2019012510585940600_ref46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005678","article-title":"Computational\u2013experimental approach to drug\u2013target interaction mapping: a case study on kinase inhibitors","volume":"13","author":"Cichonska","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"key\n\t\t\t\t2019012510585940600_ref47","doi-asserted-by":"crossref","first-page":"i232","DOI":"10.1093\/bioinformatics\/btn162","article-title":"Prediction of drug\u2013target interaction networks from the integration of chemical and genomic spaces","volume":"24","author":"Yamanishi","year":"2008","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t2019012510585940600_ref48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nbt.3374","article-title":"Comprehensive characterization of the published kinase inhibitor set","volume":"34","author":"Elkins","year":"2016","journal-title":"Nat Biotechnol"},{"key":"key\n\t\t\t\t2019012510585940600_ref49","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1158\/0008-5472.CAN-17-3644","article-title":"Patient-customized drug combination prediction and testing for T-cell prolymphocytic leukemia patients","volume":"78","author":"He","year":"2018","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019012510585940600_ref50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bib\/bbw104","article-title":"Predictive approaches for drug combination discovery in cancer","volume":"19","author":"Madani Tonekaboni","year":"2016","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t2019012510585940600_ref51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13321-018-0284-9","article-title":"Inferring potential small molecule\u2013miRNA association based on triple layer heterogeneous network","volume":"10","author":"Qu","year":"2018","journal-title":"J Cheminform"},{"key":"key\n\t\t\t\t2019012510585940600_ref52","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bax057","article-title":"NRDTD: a database for clinically or experimentally supported non-coding RNAs and drug targets associations","volume":"2017","author":"Chen","year":"2017","journal-title":"Database (Oxford)"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/advance-article-pdf\/doi\/10.1093\/bib\/bby119\/27182123\/bby119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T20:06:01Z","timestamp":1572984361000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/advance-article\/doi\/10.1093\/bib\/bby119\/5232987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,18]]},"references-count":52,"URL":"https:\/\/doi.org\/10.1093\/bib\/bby119","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,18]]}}}